Manuel Codes, MD

Articles by Manuel Codes, MD

UFT in Combination as Adjuvant Therapy for Breast Cancer

ByLuis Iglesias, MD,Jose A. Moreno, MD,Enrique Torrija, MD,Enrique Murillo, MD,Manuel Codes, MD,Antonio Duque, MD,Eduardo Garcia, MD,Jose A. Virizuela, MD

September 2nd 1997

Between 1989 and 1993, 409 evaluable patients with breast cancer have been treated with tegafur and uracil (UFT) in an adjuvant setting in two different trials. Data from both trials were reviewed in December 1995 after a

Latest Updated Articles

UFT in Combination as Adjuvant Therapy for Breast Cancer
Published: September 2nd 1997 | Updated:

Manuel Codes, MD

Articles by Manuel Codes, MD

UFT in Combination as Adjuvant Therapy for Breast Cancer

Latest Updated Articles

Trending on CancerNetwork

Novel T Cell Therapies Yield Decade-Long Remission in Epithelial Cancer

Mecbotamab Vedotin Shows Positive OS Results in Soft Tissue Sarcoma

FDA Approves Diagnostic Tool for Pembrolizumab Combo in Endometrial Cancer

ELI-002 7P Elicits Robust T-Cell Responses in KRAS+ Pancreatic Cancer

Nivolumab/Ipilimumab Improves Real-World Melanoma Outcomes Vs Pembrolizumab